Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin

Hiroyuki Onodera,1 Takeru Urayama,2 Kazue Hirota,3 Kazuhiro Maeda,3 Ritsuko Kubota-Koketsu,3,4 Kazuo Takahashi,5 Katsuro Hagiwara,6 Yoshinobu Okuno,3 Kazuyoshi Ikuta,3,4 Mikihiro Yunoki,2,4,6 1Medical Information Department, 2Research and Development Division, Japan Blood Products Organization, Toky...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Onodera H, Urayama T, Hirota K, Maeda K, Kubota-Koketsu R, Takahashi K, Hagiwara K, Okuno Y, Ikuta K, Yunoki M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	IVIG influenza seasonal neutralization vaccine Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/f64a87ea46874150b46e5d638c1f1928
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f64a87ea46874150b46e5d638c1f1928
record_format	dspace
spelling	oai:doaj.org-article:f64a87ea46874150b46e5d638c1f19282021-12-02T02:00:25ZNeutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin1177-5491https://doaj.org/article/f64a87ea46874150b46e5d638c1f19282017-03-01T00:00:00Zhttps://www.dovepress.com/neutralizing-activities-against-seasonal-influenza-viruses-in-human-in-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Hiroyuki Onodera,1 Takeru Urayama,2 Kazue Hirota,3 Kazuhiro Maeda,3 Ritsuko Kubota-Koketsu,3,4 Kazuo Takahashi,5 Katsuro Hagiwara,6 Yoshinobu Okuno,3 Kazuyoshi Ikuta,3,4 Mikihiro Yunoki,2,4,6 1Medical Information Department, 2Research and Development Division, Japan Blood Products Organization, Tokyo, 3Research and Development Division, The Research Foundation for Microbial Diseases of Osaka University, Kagawa, 4Former Department of Virology, Research Institute for Microbial Diseases, Osaka University, 5Virology Division, Department of Infectious Diseases, Osaka Prefectural Institute of Public Health, Osaka, 6Pathogenic Risk Evaluation, Graduate School of Veterinary Medicine, Rakuno Gakuen University, Hokkaido, Japan Abstract: Influenza viruses A/H1N1, A/H3N2, and B are known seasonal viruses that undergo annual mutation. Intravenous immunoglobulin (IVIG) contains anti-seasonal influenza virus globulins. Although the virus-neutralizing (VN) titer is an indicator of protective antibodies, changes in this titer over extended time periods have yet to be examined. In this study, variations in hemagglutination inhibition (HI) and VN titers against seasonal influenza viruses in IVIG lots over extended time periods were examined. In addition, the importance of monitoring the reactivity of IVIG against seasonal influenza viruses with varying antigenicity was evaluated. A/H1N1, A/H3N2, and B influenza virus strains and IVIG lots manufactured from 1999 to 2014 were examined. The HI titer was measured by standard methods. The VN titer was measured using a micro-focus method. IVIG exhibited significant HI and VN titers against all investigated strains. Our results suggest that the donor population maintains both specific and cross-reactive antibodies against seasonal influenza viruses, except in cases of pandemic viruses, despite major antigen changes. The titers against seasonal influenza vaccine strains, including past strains, were stable over short time periods but increased slowly over time. Keywords: IVIG, influenza, seasonal, neutralization, vaccineOnodera HUrayama THirota KMaeda KKubota-Koketsu RTakahashi KHagiwara KOkuno YIkuta KYunoki MDove Medical PressarticleIVIGinfluenzaseasonalneutralizationvaccineMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol Volume 11, Pp 23-30 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	IVIG influenza seasonal neutralization vaccine Medicine (General) R5-920
spellingShingle	IVIG influenza seasonal neutralization vaccine Medicine (General) R5-920 Onodera H Urayama T Hirota K Maeda K Kubota-Koketsu R Takahashi K Hagiwara K Okuno Y Ikuta K Yunoki M Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
description	Hiroyuki Onodera,1 Takeru Urayama,2 Kazue Hirota,3 Kazuhiro Maeda,3 Ritsuko Kubota-Koketsu,3,4 Kazuo Takahashi,5 Katsuro Hagiwara,6 Yoshinobu Okuno,3 Kazuyoshi Ikuta,3,4 Mikihiro Yunoki,2,4,6 1Medical Information Department, 2Research and Development Division, Japan Blood Products Organization, Tokyo, 3Research and Development Division, The Research Foundation for Microbial Diseases of Osaka University, Kagawa, 4Former Department of Virology, Research Institute for Microbial Diseases, Osaka University, 5Virology Division, Department of Infectious Diseases, Osaka Prefectural Institute of Public Health, Osaka, 6Pathogenic Risk Evaluation, Graduate School of Veterinary Medicine, Rakuno Gakuen University, Hokkaido, Japan Abstract: Influenza viruses A/H1N1, A/H3N2, and B are known seasonal viruses that undergo annual mutation. Intravenous immunoglobulin (IVIG) contains anti-seasonal influenza virus globulins. Although the virus-neutralizing (VN) titer is an indicator of protective antibodies, changes in this titer over extended time periods have yet to be examined. In this study, variations in hemagglutination inhibition (HI) and VN titers against seasonal influenza viruses in IVIG lots over extended time periods were examined. In addition, the importance of monitoring the reactivity of IVIG against seasonal influenza viruses with varying antigenicity was evaluated. A/H1N1, A/H3N2, and B influenza virus strains and IVIG lots manufactured from 1999 to 2014 were examined. The HI titer was measured by standard methods. The VN titer was measured using a micro-focus method. IVIG exhibited significant HI and VN titers against all investigated strains. Our results suggest that the donor population maintains both specific and cross-reactive antibodies against seasonal influenza viruses, except in cases of pandemic viruses, despite major antigen changes. The titers against seasonal influenza vaccine strains, including past strains, were stable over short time periods but increased slowly over time. Keywords: IVIG, influenza, seasonal, neutralization, vaccine
format	article
author	Onodera H Urayama T Hirota K Maeda K Kubota-Koketsu R Takahashi K Hagiwara K Okuno Y Ikuta K Yunoki M
author_facet	Onodera H Urayama T Hirota K Maeda K Kubota-Koketsu R Takahashi K Hagiwara K Okuno Y Ikuta K Yunoki M
author_sort	Onodera H
title	Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
title_short	Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
title_full	Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
title_fullStr	Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
title_full_unstemmed	Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
title_sort	neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/f64a87ea46874150b46e5d638c1f1928
work_keys_str_mv	AT onoderah neutralizingactivitiesagainstseasonalinfluenzavirusesinhumanintravenousimmunoglobulin AT urayamat neutralizingactivitiesagainstseasonalinfluenzavirusesinhumanintravenousimmunoglobulin AT hirotak neutralizingactivitiesagainstseasonalinfluenzavirusesinhumanintravenousimmunoglobulin AT maedak neutralizingactivitiesagainstseasonalinfluenzavirusesinhumanintravenousimmunoglobulin AT kubotakoketsur neutralizingactivitiesagainstseasonalinfluenzavirusesinhumanintravenousimmunoglobulin AT takahashik neutralizingactivitiesagainstseasonalinfluenzavirusesinhumanintravenousimmunoglobulin AT hagiwarak neutralizingactivitiesagainstseasonalinfluenzavirusesinhumanintravenousimmunoglobulin AT okunoy neutralizingactivitiesagainstseasonalinfluenzavirusesinhumanintravenousimmunoglobulin AT ikutak neutralizingactivitiesagainstseasonalinfluenzavirusesinhumanintravenousimmunoglobulin AT yunokim neutralizingactivitiesagainstseasonalinfluenzavirusesinhumanintravenousimmunoglobulin
_version_	1718402810343587840

Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin

Ejemplares similares